AIM: We explored the role of SNPs within the SLCO1B3, SLCO1B1, SLC22A6, ABCB1, ABCG2, SLCO3A1, CYP2C19, ABCC2, SLC22A1, ABCB11 and NR1I2 genes on voriconazole pharmacokinetics. PATIENTS & METHODS: 233 pediatric patients were enrolled. Drug plasma Ctrough was measured by a HPLC-MS method. Allelic discrimination was performed by qualitative real-time PCR. RESULTS: SLCO1B3 rs4149117 c.334 GT/TT (p = 0.046), ABCG2 rs13120400 c.1194 + 928 CC (p = 0.029) and ABCC2 rs717620 c.-24 GA/AA (p = 0.025) genotype groups significantly influenced Ctrough. ethnicity (p = 0.042), sex (p = 0.033), SLCO1B3 rs4149117 c.334 GT/TT (p = 0.041) and ABCB1 rs1045642 c.3435 TT (p = 0.016) have been retained in linear regression model as voriconazole predictor factors. CONCLUSION: Understanding how some gene polymorphisms affect the voriconazole pharmacokinetic is essential to optimally dose this agent.
AIM: We explored the role of SNPs within the SLCO1B3, SLCO1B1, SLC22A6, ABCB1, ABCG2, SLCO3A1, CYP2C19, ABCC2, SLC22A1, ABCB11 and NR1I2 genes on voriconazole pharmacokinetics. PATIENTS & METHODS: 233 pediatric patients were enrolled. Drug plasma Ctrough was measured by a HPLC-MS method. Allelic discrimination was performed by qualitative real-time PCR. RESULTS:SLCO1B3rs4149117c.334 GT/TT (p = 0.046), ABCG2rs13120400 c.1194 + 928 CC (p = 0.029) and ABCC2rs717620 c.-24 GA/AA (p = 0.025) genotype groups significantly influenced Ctrough. ethnicity (p = 0.042), sex (p = 0.033), SLCO1B3rs4149117c.334 GT/TT (p = 0.041) and ABCB1rs1045642 c.3435 TT (p = 0.016) have been retained in linear regression model as voriconazole predictor factors. CONCLUSION: Understanding how some gene polymorphisms affect the voriconazole pharmacokinetic is essential to optimally dose this agent.
Entities:
Keywords:
ABCB1; ABCC2; ABCG2; SLCO1B3; therapeutic drug monitoring; triazoles
Authors: Jessica Cusato; Alice Palermiti; Alessandra Manca; Jacopo Mula; Miriam Antonucci; Amedeo De Nicolò; Sarah Allegra; Silvia De Francia; Francesco Chiara; Giovanni Di Perri; Francesco Giuseppe De Rosa; Andrea Calcagno; Antonio D'Avolio Journal: Pharmaceuticals (Basel) Date: 2022-05-20
Authors: Takuto Takahashi; Angela R Smith; Pamala A Jacobson; James Fisher; Nathan T Rubin; Mark N Kirstein Journal: Antimicrob Agents Chemother Date: 2020-11-17 Impact factor: 5.191
Authors: Romy Tilen; Paolo Paioni; Aljoscha N Goetschi; Roland Goers; Isabell Seibert; Daniel Müller; Julia A Bielicki; Christoph Berger; Stefanie D Krämer; Henriette E Meyer Zu Schwabedissen Journal: Pharmaceutics Date: 2022-06-17 Impact factor: 6.525
Authors: Takuto Takahashi; Maryam A Mohamud; Angela R Smith; Pamala A Jacobson; Mutaz M Jaber; Abeer F Alharbi; James Fisher; Mark N Kirstein Journal: Antimicrob Agents Chemother Date: 2021-08-17 Impact factor: 5.191